Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Researchers tested an unexpected addition to vaginal treatment: oxygen (opens in a new tab)

news-medical.net · 2026-10-28

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 2 supported
  • 5 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Every claim we could check holds up. Two of seven claims match the study. This overall rating is based only on the claims we could check. Five claims the study doesn't address.

  • 2 supported
  • 5 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7Not coveredThe study was described as an exploratory, randomized, open-label pilot study at the University Hospital of Modena in Italy, involving 22 symptomatic women aged 18 to 45 with BV or non-specific vaginitis split evenly between oxygen alone and oxygen plus antimicrobial treatment.View evidenceHide evidence

As stated22 women; 11 per arm

Why this verdict

The abstract-level profile supports an exploratory clinical study with 22 symptomatic women with BV or vulvovaginitis assigned to oxygen alone or oxygen plus systemic antimicrobials. However, randomization, open-label status, site, age range, exact diagnosis wording of non-specific vaginitis, and an even 11-per-arm split are not fully specified in the abstract profile; randomization/blinding are explicitly described as not specified at this depth.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
2

Study evidence

Topical oxygen alone increased the number of 'negative' clinical swabs from 4 (36.4%) at baseline to 9 (81.8%) at 10–14 days post-treatment.4/11 (36.4%) → 9/11 (81.8%); p = 0.06

“Vaginal microbiota composition, pH and Lactobacillus presence were evaluated at baseline and 10–14 days post-treatment”
Claim 2 of 7Not coveredIn the oxygen-only arm, the article says pH stayed about the same, swab negativity rose from 4 of 11 to 9 of 11, and total Lactobacillus abundance remained high and stable; none of the observed genus-level shifts was individually significant.View evidenceHide evidence

As stated4/11 to 9/11 negative swabs; median pH 4.50 unchanged; Lactobacillus 92.6% to 91.5%

Why this verdict

The abstract profile supports the oxygen-only arm’s negative swab increase from 4/11 to 9/11 with p=0.06 and stable high Lactobacillus relative abundance around 92.6% to 91.5%. However, numeric pH results are not reported in the abstract profile, and the statement that no genus-level shifts were individually significant is not verifiable from the supplied abstract-depth evidence.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
2

Study evidence

Topical oxygen alone increased the number of 'negative' clinical swabs from 4 (36.4%) at baseline to 9 (81.8%) at 10–14 days post-treatment.4/11 (36.4%) → 9/11 (81.8%); p = 0.06

“Vaginal microbiota composition, pH and Lactobacillus presence were evaluated at baseline and 10–14 days post-treatment”
Claim 3 of 7Not coveredIn the oxygen-plus-antimicrobial arm, the article says total Lactobacillus abundance increased, strict anaerobes decreased significantly, and individual genera including Atopobium and Sneathia fell, while Streptococcus and Staphylococcus increased.View evidenceHide evidence

As statedLactobacillus 49.1% to 85.2%; strict anaerobes 24.8% to 9.0%

Why this verdict

The abstract profile supports that oxygen plus antimicrobial therapy reduced strict anaerobes from 24.8% to 9.0% with p=0.05 and decreased BV-associated genera including Atopobium and Sneathia. But the specific Lactobacillus increase from 49.1% to 85.2% and increases in Streptococcus and Staphylococcus are not present in the supplied abstract-level profile, so the full claim cannot be verified at this depth.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
Claim 4 of 7Not coveredThe article says the authors interpreted the findings as preliminary evidence that topical oxygen may help alter the vaginal microbiota, particularly as an adjunct to antimicrobial therapy, but that the study was hypothesis-generating only and called for larger sham-controlled trials.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the preliminary, hypothesis-generating interpretation and the call for larger trials to assess clinical efficacy and recurrence prevention. The more specific statement that the authors called for larger sham-controlled trials is not verifiable from the abstract profile, which notes lack of non-oxygen controls but does not specify a sham-controlled trial recommendation.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
2

Study evidence

Topical oxygen alone increased the number of 'negative' clinical swabs from 4 (36.4%) at baseline to 9 (81.8%) at 10–14 days post-treatment.4/11 (36.4%) → 9/11 (81.8%); p = 0.06

“Vaginal microbiota composition, pH and Lactobacillus presence were evaluated at baseline and 10–14 days post-treatment”
Claim 5 of 7Not coveredThe study reported no adverse events over short-term follow-up and was described as well tolerated and acceptable to participants.View evidenceHide evidence

As stated0 adverse events among 22 women

Why this verdict

The supplied abstract-level profile does not report adverse-event counts, tolerability, or participant acceptability. The claim may come from full-text material, but it is not verifiable from the provided abstract-depth paper profile.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
Claim 6 of 7SupportedResearchers tested whether increasing oxygen levels in the vagina could change the balance between protective bacteria and microbes associated with infection in women with bacterial vaginosis and vaginitis.View evidenceHide evidence

Why this verdict

At headline prominence, this is supported by the abstract-level profile: the paper evaluated topical vaginal oxygen, alone or with antimicrobials, as a way to modulate vaginal microbiota composition in symptomatic women with BV or vulvovaginitis. The wording is broad and study-framed rather than claiming proven clinical efficacy or causality. The abstract does not show measured vaginal oxygen tension, but it does support that topical oxygen delivery was the intervention being tested.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
Claim 7 of 7SupportedA recent study published in Microorganisms described changes in the vaginal microbiome after topical oxygen treatment, alone or combined with antimicrobials, but the article says the study cannot establish whether oxygen itself caused those changes.View evidenceHide evidence

Why this verdict

The profile supports that the study reported pre–post microbiome changes after topical oxygen alone or topical oxygen plus antimicrobials, and its limitations support the story’s caution that effects cannot be attributed specifically to oxygen because both arms received oxygen and there was no non-oxygen comparator. The claim is appropriately associational and hedged.

1

Study evidence

Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06

“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
2

Study evidence

Topical oxygen alone increased the number of 'negative' clinical swabs from 4 (36.4%) at baseline to 9 (81.8%) at 10–14 days post-treatment.4/11 (36.4%) → 9/11 (81.8%); p = 0.06

“Vaginal microbiota composition, pH and Lactobacillus presence were evaluated at baseline and 10–14 days post-treatment”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Intervention details: oxygen was delivered using the Caress Flow device at 3 L/min for 20 minutes, twice weekly for 2 weeks.

    The story presentation describes topical intravaginal oxygen generally but does not reflect the device, flow rate, session length, or treatment schedule reported in the profile.

    From exploratory interventional clinical pre–post; Pre–post interventional (two-arm: topical oxygen alone vs topical oxygen +

7 things the story did carry across
  • Primary study aim: evaluate whether topical vaginal oxygen, alone or adjunctive to systemic antimicrobials, modulates vaginal microbiota composition in symptomatic women with BV or vulvovaginitis over about two weeks.
  • Study design and population: 22 symptomatic women with BV or vulvovaginitis were assigned to topical oxygen alone or topical oxygen plus systemic antimicrobial therapy, with baseline and 10–14 day post-treatment assessment.
  • Oxygen-only results: negative swabs increased from 4/11 to 9/11 with p=0.06, and total Lactobacillus relative abundance remained high and largely unchanged.
  • Oxygen plus antimicrobial results: strict anaerobes decreased from 24.8% to 9.0% with p=0.05, and BV-associated genera including Atopobium and Sneathia decreased.
  • The findings are preliminary and trend-like, with larger trials needed to assess clinical efficacy and recurrence prevention.
  • Major limitations include small sample size, short 10–14 day follow-up, lack of non-oxygen comparator/control arms, and limited ability to attribute effects specifically to oxygen.
  • Microbiome results are based on 16S sequencing and relative-abundance comparisons, with multiple microbiome outcomes and limited information on multiplicity adjustment.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEvaluate whether topical oxygen treatment (alone or adjunctive to systemic antimicrobials) favorably modulates vaginal microbiota composition in symptomatic women with BV/vulvovaginitis over ~2 weeks.exploratory interventional clinical pre–postExpand

In plain English

Exploratory clinical study (n=22) evaluated topical vaginal oxygen delivered via Caress Flow (3 L/min, 20 min, twice weekly for 2 weeks) given alone or combined with systemic antimicrobial therapy. Vaginal swabs were assessed by 16S metagenomic sequencing at baseline and 10–14 days post-treatment. Topical oxygen alone showed a rise in negative swabs and stable high Lactobacillus relative abundance; oxygen plus antimicrobials reduced strict anaerobes and decreased BV-associated genera. Findings are preliminary and support larger trials.

Key findings

  • Topical oxygen alone increased the number of negative swabs from 4 (36.4%) to 9 (81.8%) with p = 0.06.Negative swabs: 36.4% → 81.8%; p = 0.06
  • Topical oxygen alone maintained high total Lactobacillus spp. relative abundance (reported as 92.60% [67.88–96.16%] at baseline and 91.50% [87.4–95.0%] post-treatment as reported).Lactobacillus spp. relative abundance: 92.60% [67.88–96.16] → 91.50% [87.4–95.0%]
“Twenty-two symptomatic women affected by either BV or vulvovaginitis were enrolled and assigned to either topical oxygen or standard antimicrobial treatment plus topical oxygen.”
What this piece can’t prove
  • Exploratory study with small overall sample size (n = 22); limited power for subgroup or definitive statistical conclusions.
  • Short follow-up (10–14 days) reported; longer-term clinical outcomes and recurrence prevention were not assessed here.
  • Abstract does not specify details of the systemic antimicrobial regimens, limiting interpretation of adjunctive effects.

2 further details could not be confirmed from the summary.

2human in vivoAssess whether oxygen-based regimens improve related vaginal measures (pH, Lactobacillus presence/negative swab status) from baseline to post-treatment.Pre–post interventional (two-arm: topical oxygen alone vs topical oxygen + systemic antimicrobial)Expand

In plain English

Pre–post clinical assessment (n=22) of topical oxygen (Caress Flow device; 3 L/min, 20 min, twice weekly for 2 weeks) given either alone or plus systemic antimicrobial; vaginal pH, clinical/point-of-care swab status ('negative swab'), and Lactobacillus presence were measured at baseline and 10–14 days post-treatment. Topical oxygen alone was associated with an increase in negative swabs (reported 4 [36.4%] → 9 [81.8%], p = 0.06). Reported total Lactobacillus spp. abundance remained high across the sampling interval (92.60% [67.88–96.16] at baseline and 91.50% [87.4–95.0] after treatment as reported). Vaginal pH was listed as assessed but no numerical pH results are reported in the abstract. Findings are preliminary, from a small sample, and both study arms received oxygen (with or without adjunctive systemic antimicrobial), limiting inference about oxygen vs non-oxygen comparators.

Key findings

  • Topical oxygen alone increased the number of 'negative' clinical swabs from 4 (36.4%) at baseline to 9 (81.8%) at 10–14 days post-treatment.4/11 (36.4%) → 9/11 (81.8%); p = 0.06
  • Total Lactobacillus spp. abundance was reported as high and largely unchanged between baseline and post-treatment.92.60% [67.88–96.16] at baseline vs 91.50% [87.4–95.0] after treatment (as reported in abstract)
“Vaginal microbiota composition, pH and Lactobacillus presence were evaluated at baseline and 10–14 days post-treatment”
What this piece can’t prove
  • Small sample size (n=22) limits precision and generalizability of reported changes.
  • Follow-up interval is short (10–14 days post-treatment) — longer-term outcomes and recurrence prevention not assessed in the reported data.

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

Europe PMC, Crossref, PubMed · 39 candidate papers

Candidate

Genome-edited animals and microorganisms (ITA Dossier No.85en, Nov. 2025; Author: Karen Kastenhofer)

2026 · Crossref

Source (opens in a new tab)
Candidate

Author comment: From paper to practitioner: Strategies for incorporating soil microorganisms into dryland restoration — R3/PR14

2026 · Crossref

Source (opens in a new tab)
Candidate

Author comment: From paper to practitioner: Strategies for incorporating soil microorganisms into dryland restoration — R2/PR11

2026 · Crossref

Source (opens in a new tab)

And 33 more candidates considered.